Specsavers’ latest snapshot into Australian eye health has revealed referrals for eye disease are soaring to unprecedented levels thanks to the systematic use of imaging technology and ophthalmology-led education, as well as other clinical interventions. Read more
Multinational biotech company Biogen has proposed a deal worth up to US$310 million (AU$453 m) to supply biosimilar treatments of Lucentis and Eylea to major global markets, including Australia. Read more
For the second year in a row George & Matilda Eyecare has been recognised with top honours at the Australian Growth Company Awards. Read more
The Brien Holden Vision Institute (BHVI) has signed a licensing agreement that will see its algorithms for tracking and estimating refractive error incorporated into a world-first instrument for myopia management. Read more
The Australian College of Optometry (ACO) has established a public health optometry clinic in a new state responding to unmet eyecare needs in both the general population and disadvantaged communities. Read more
International charity Optometry Giving Sight (OGS) has announced a new board of directors who will steer the organisation towards new priorities. Read more
The Fred Hollows Foundation’s CEO Mr Ian Wishart has been awarded the 2019 Chancellor’s Alumni Award from the University of Canberra in recognition of his contributions to the international humanitarian sector. Read more
Novartis has secured US regulatory approval for Beovu, the company’s latest therapy for neovascular age-related macular degeneration (nAMD), following the drug’s comparable results in head-to-head trials with Eylea. Read more
The Lions Eye Institute (LEI) has signed a commercial partnership that will combine its antisense gene therapy for a leading cause of childhood blindness with a new Australian-developed drug delivery platform. Read more
Research lead Dr Felicity de Cogan from the university’s Institute of Microbiology and Infection revealed her team has invented a method that has had Read more